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Test yourself with condence using the same test your doctor uses|but in
the privacy of your home!~
| Instructions for a proposed AIDS home test kit
I. INTRODUCTION
Human imunodeciency x'inis disease is the most serious communicable
epidemic in contemporary times. The challenges HIV disease presents are
formidable: it cannot yet be cured or prevented. camers are chronically in-
fectious, and those at greatest risk are some of our citizens most vulnerable
to social discrimination and private prejudice. By the end of 1991 there were
200.0% reported cases of AIDS in the United States and public health ocials
estimate that another one million people are currently HIV-infected. The over-
whelming majority|estimates range from 75% to 90% | of those carrying the
HIV virus are unaware that they are infected.
The focal point of the many controversies surrounding AIDS is testing. Once
a test for antibodies to the AIDS virus was developed, the issue of mandatory
testing or screening immediately arose. Those opposed to wide-scale testing,
convinced condentiality could not be maintained, cited concerns of privacy,
liberty, and social and economic discrimination. Others asserted that protection
of the communal well-being demanded compulsory testing. While routine test-
ing of the blood supply went unchallenged, calls for a far-reaching authoritarian
public health response lost to the voluntarist consensus. Public health ocials
and legislatures concluded that compulsory testing, whether mass or targeted,
would be prohibitively expensive, that it would lead to invidious discrimination,
particularly against homosexuals and drug users, and that the history of public
health measures demonstrated most coercive measures to be of dubious ecacy.
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Thus, with federal funding and support we created a network of free, con-
dential and anonymous testing centers. Thirty-six states have enacted informed
consent and condentiality legislation governing AIDS testing.1 To address con-
cerns of condentiality, there is no federal requirement to report seropositive
results to public health ocials; data is only collected on the actual onset of
AIDS. Underlying these voluntarist strategies is the belief that more people will
be tested under these conditions, beneting both individuals and the public
welfare.
Given the emphasis on private, condential and voluntary testing, the idea
of an AIDS home test kit was inevitable. What could be more private, con-
dential and voluntary (and protable) than buying a test kit at a drug store to
take home and use? in 1986 the Food and Drug Administration (FDA) began
receiving applications for various kinds of AIDS home test kits and immediately
found itself at the center of a political maelstrom. Congressional subcommittees,
AIDS activists, the gay community, doctors and scientists were quickly pitted
against several entrepreneurs interested in bringing these products to market.
FDA responded by refusing to even consider and evaluate any applications for
AIDS home test kits for several years. Finally, in 1990 the FDA eectively re-
versed this policy and with little controversy began accepting applications for
the kits.
In this paper I want to assess the FDA's and the public's evolving response
to the idea of AIDS home tests. Additionally, what is the FDA's role in a public
health crisis such as the AIDS epidemic? What are legitimate criteria for FDA
to weigh when evaluating a product such as an AIDS home test kit? More
generally, are AIDS home test kits good public policy? I begin by sketching a
brief history of the FDA~s regulation of the product. Next I discuss the various
arguments for and against an AIDS home test. I conclude with an analysis of
the FDA's role in a debate such as this and some thoughts on the politics of
AIDS.
I Burns, Scott, 'Tcsting, Disclosure, and the Right to Privacy, AIDS Law
Today, ed. Burris, 115. 121 (1993).
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Any debate about the AIDS problem requires an understanding of what the
problem is, and on that front there is frequent disagreement. Like epidemics
throughout history, HIV disease is as much a political, cultural and social phe-
nomenon as it is a biological one. Thus, it is hardly surprising that the AIDS
debate in this country is emotionally and politically charged on all sides. For
instance, partly because the majority of the early victims were homosexual men,
the disease acquired a devastating stigma, and many people continue to concep-
tualize AIDS as divine retribution for a sinful lifestyle. On the other side, the
gay community vigorously and successfully politicized the public discourse as a
tactical measure in the ght against AlDS. For both groups, AIDS holds special
signicance. Any discussion of AIDS policy must bear in mind that AIDS has
become more than a medical condition.
II. FDA REGULATION OF AIDS HONIE TEST KITS
Home Test Kits: There are two kinds of AIDS home test kits. The rst
is known as a home performance kit and is similar to the home pregnancy tests.
The user conducts the test and interprets the results in his or her home. No
such legitimate devices have appeared on the market, although the technology
for such a home test is on the horizon.The second category consists of blood
collection kits. The kits contain a skin
disinfectant, a lancet for self-blood letting, a capillary tube or other collection
medium, cotton or gauze, a bandage, and an instruction booklet. The user draws
a blood sample which he or she then sends in a supplied mailing package to a
laboratory where the blood is tested for the presence of antibodies to the WV
virus. The user later phones the testing center using a coded number to obtain
the results and counseling. The AIDS home tests
2 The FDA is nearing completion of the review process for an AIDS test
developed by Epitope which uses saliva rather than blood. The Gray SIieei
(November 15, 1993).
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proposed so far have been blood collection kits and these are what I will be
discussing unless otherwise noted.
Regulatory Framework and History: AIDS home test kits are medical
devices subject to FDA regulation under the Medical Device Amendments of
1976 to the Food, Drug and Cosmetics Act. In 1987 the FDA classied AIDS
home test kits as Class III medical devices which require clinical testing for
safety and eectiveness and premarket approval (PMA) prior to marketing.3
As interest in the home diagnostic kits grew, the FDA transferred authority
over them from the Center for Devices and Radiological Health to the Center
for Biologics Evaluation and Research which was already deeply involved in the
AIDS epidemic.
In 1987 a company called Universal Health Laboratories submitted a PMA
for a blood collection kit. By this time, there was pressure on FDA from several
fronts, tncluding Congress and AIDS activists, to keep AIDS home test kits o
the market. Concerns were voiced about test performance and safety, conden-
tiality, and counseling. In response. the FDA issued ve draft points to consider
for any applicants seeking PMAs for AIDS diagnostic kits.
(I) The kits must be labeled and marketed for professional use only
within a comprehensive health care environment.
(2) The kit must provide for blood drawing by a licensed authority.
(3) A licensed screening test for HIV antibodies must be used. When
the screening test yields a positive result, it must be conrmed using a more
specic, licensed test such as the Western Blot.
(4) The kit's instructions must be the equivalent of the package in-
sert for the licensed antibody test used.
(5) All test results must be reported to a professional health care provider
for interpretation, reporting and counseling.4
Depending on your position, the FDA was either being cautious or imposing
a de facto ban on home test kits for AIDS. Relying on these draft points and
concerns raised by advisory groups and interested parties, in March 1988 the
FDA declined to le Universal
~ Unapproved AIDS Home Test Kits, FDA Talk Paper No. T87-35
(July 23. 1987).
~ 53 Fed. Reg. 46118 (November 16. 1988).
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Health Laboratories' PMA application, thus refusing to even look at the
data and research. The FDA did eventually announce that hearings would be
held on the issue, a few weeks after a House subcommittee hearing on the same
topic.5
The FDA and congressional hearings were primarily opportunities to test
the political winds. The majority of the witnesses representing the FDA, AIDS
clinics, and the medical profession opposed the AIDS home test kits for a variety
of reasons, as discussed below. In fact, Representative Ron Wyden convened
the subcommittee hearing because he was dismayed to hear that the FDA may
reverse its opposition to AIDS home testing kits.t ~ The only vigorous dissent
to the FDA's restrictions on the diagnostic kits came interested entrepreneurs
such as Eliot Millenson, founder of Universal Health Laboratories. FDA took
no action on the kits for the next year.
Then, in the spring of 1990 the FDA announced that it would welcome
applications for AIDS home test kits? Although the agency said the ve criteria
listed above were still valid, the implicit message was that the FDA was at least
willing to look at the data and research. At the same time the FDA reached
a settlement in a lawsuit led by Universal Health Laboratories.8 As part of
the settlement, the company's PMA was led and evaluated. In August 1990,
however, the FDA denied Universal Health Laboratories a PMA on a number
of grounds, as discussed below.9
As of this date, the FDA has not approved an AIDS home test kit.
III. THE DEBATE OVER AIDS HOME TEST KITS
Test Performance and Safety: Can an AIDS test be safely and eectively
used in the home by nonprofessionals? The answer depends largely on what is
meant by an AIDS home test. If the test is one in which the home user draws
the blood, administers
54 Fed. Reg. 7279 (February 17, 1989).
6 The Gray Sheet. 3 (March 20, 1989).
~ Applications for AIDS Home Test Kits, FDA Talk Paper NO.
T90-20 (April 30, 1990).
8 The Gray Slieci , 9(April 30, 1990).
~ Letter from FDA to University Hospital Laboratories (August 6,
1990).
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the test, and interprets the results, serious concerns about reliability and
eectiveness are justied. For example, the public has diculty correctly using
and reading home pregnancy tests. ~ Laboratory technicians undergo consider-
able training before conducting and interpreting AIDS tests|it is not as simple
as mixing two test tubes and noting the color. If the test was made more rugged
to accommodate the inexperience of home users as is sometimes done with other
home test kits, reliability and accuracy may be sacriced.
If the AIDS home test is simply a blood collection mechanism, however, test
performance concerns are lessened. Once the blood specimen is collected, it can
be mailed to a laboratory where the standard ELISA screening test and conr-
matory Western Blot test can be applied just as if the sample had come from
a public clinic. With a blood collection device, the reliability and eectiveness
concerns are limited to issues of collection and transportation: Can a member
of the general public collect a blood sample safely and get it to the laboratory
in good condition? There are other home test kits currently on the market that
require the user to collect a blood sample, so the prospect cannot be casually
dismissed. Strict labeling and instruction requirements which take into account
the abilities of dierent socioeconomic groups would be necessary. Most propos-
als for AIDS home kits employ the ngerprick method, however, some scientists
have raised questions regarding the public's ability to collect an uncontaminated
specimen using this method.' Further speculation has been broached about the
possibility of transmitting the AIDS virus to other household members via dis-
carded materials from the test. To counter this concern some AlDS home tests
proposals included instructions to mail the used lancet with the blood sample.
But the risk of contracting AIDS from a discarded lancet surely cannot be any
greater than that from normal daily activities. Public health ocials have gone
out their way to assure the public that AIDS is not transmitted through daily
household contact.
10 Testimony of Stephen Bowen, M.D., Deputy Director for AIDS and HIV
in the Center for Prevention Studies at the Center for Disease Control , Open
public meeting on Blood Collection Kits labeled for Human Immunodeciency
Virus Type I Antibody Testing, 48 (April 6, 1989).
~ The Gray Sheet, 6 (May 15. 1989).
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Once the blood sample is collected, can it be safely and securely transported
to the testing laboratory? Postal workers have expressed concern about the
mailing of potentially HIV-tnfected blood. Their apprehension is misplaced,
however, because large quantities of blood and medical specimens are mailed
everyday. The solution is to require packaging sucient to allay fears of possible
contamination and to train postal workers in the handling of medical specimens.
Transportation concerns are further minimized by the emergence of a lter pa-
per technology employed by some AIDS home test kit proposals. Rather than
submitting a vial of blood for testing (which raises further questions about fresh-
ness and shipping delays), the user mails a dried blood sample captured on lter
paper.
Even with a blood collection device, the problems of false positives and
negatives remain. When a test is less than 100% sensitive, some people who
ha~'e the disease will not test positive|these are false negatives. When a test
is less than 100% specic, some people who do not ha~'e the disease will test
positive|these are false positives. With a home test kits, false positives pose the
greatest problems. First, the predictive values of the AIDS tests are inuenced
by the prevalence of the disease in the test population. Thus, the lower the
number of truly infected people in a population, the higher the number of false
positives that will register. Because of false positives, it is standard procedure
for laboratories to subject all positive results to a conrmatory test. Only if the
second test also yields a positive result is the person notied that they are HIV
positive. Any AIDS home test of the blood collection nature can easily follow
the conrmatory test procedure. Of perhaps greater concern is the psychological
consequences inicted on people who falsely test positive. Yet this issue must be
addressed in both traditional and home testing situations and will be considered
below in the discussion of counseling.
Finally, laboratories that conduct AIDS tests are subject to quality control
standards and postmarket surveillance to insure accuracy and reliability. When
an inexperienced, one-time home user is conducting the test, the need for quality
control is, if anything,
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greater. Still, the premarket approval requirement insures that the tests meet
certain standards. The FDA can monitor and regulate the manufacturer of the
test and the actual testing laboratory. Further, the FDA has a Medical Device
Reporting program which requires the makers of all medical devices to report
all adverse eects. Unfortunately, there is usually poor postinarket monitoring
of home test kits, largely because consumers do not report all incidents to the
makers. yet the FDA still allows many home diagnostics to remain on the
market.
Condentiality: One of, if not the central reason oered for the marketing
of an AIDS home test kit is that many people who would not otherwise be tested
would purchase such a kit. Behind this analysis are the condentiality concerns
repeatedly expressed by the public. AIDS activists and public health ocials.
In one survey, a third of those who want to be tested for AIDS say they will
do so only with a home test because they do not believe other methods guard
their anonymity. About sixty percent of those surveyed said they would prefer
a home test over going to a doctor of clinic.t2 People are afraid that employers,
insurers, landlords will discover their serostatus and discriminate against them.
Others, especially members of groups such as racial minorities and homosexuals
who have historically been discriminated against, fear mandatory public health
reporting requirements.
To address these condentiality concerns public health ocials instituted
condential and anonymous testing centers across the country. Yet now, conft-
dentiality justications for an AIDS home test are dismissed by many parties,
who point to the public clinics as sucient. Although most people do have
access through either the public or private sector to AIDS testing, the question
is more appropriately whether people, particularly those in high-risk groups,
actually take advantage of these resources, and if




not, whether they would purchase an AIDS test they could administer in
the privacy of their home. At a minimum, this issue warrants research.
Ironically, at the same time that condentiality concerns are deemed illegit-
imate, fears that condentiality will be breached with home tests are used to
reject them. Current home test proposals envision a system where the client
calls the testing center anonymously, using a coded number to receive their re-
sults. Although someone might secure the number and use it to obtain another's
results, the possibility of paper falling into the wrong hands exists even when
a person is notied through traditional channels. Actually, the primary breach
of condentiality most frequently comes from the individual herself. Because
home users may fail to appreciate the risks of sharing their serostatus, there
should be counseling on this matter.
Counseling: Probably the most controversial aspect of home testing for AIDS
is over counseling. Knowledge of one's serostatus is useless without accompa-
nying information about what it means. There is little disagreement that coun-
seling is necessary (lito help an individual decide whether to take an AIDS test,
(2) to help an individual cope with the immediate psychological reactions to
the test results, which frequently include suicide ideation or attempts, (3) to
provide information about behavior changes and partner notication, and (4)
to refer the individual to medical and support services. All publicly funded clin-
ics must provide extensive face-to-face counseling both before administering an
AIDS test and when reporting the results. Similarly, counseling in conjunction
with an AIDS test is a part of the accepted standard of care in the medical
profession, although it is not always given in the private sector.
Given that counseling is an accepted component of AIDS testing, can it be
provided in the context of home tests? In addition to the information booklet
and toll free numbers that would be included with a home test kit, telephone
counseling is provided when the user calls in for the results. Advocates of
prohibiting the use of AIDS home test kits claim that face-to-face counseling is
the only appropriate method in the circumstances. They
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argue that to be eective a counselor must gauge an individual's needs partly
through reliance on techniques such as maintaining eye contact and reading body
language, and also through a knowledge of what result they expect and the social
network on which they can draw. Opponents also question whether counselors
at a national telephone center can direct individuals to the appropriate local
services.
Dismissing telephone counseling out of hand, however, is premature and
presumptive. First, the true test of any counseling is the quality, not merely
the context. Second, the question cannot be intelligently resolved without a
comparison between face-to-face and telephone counseling in the context of HIV
counseling. Currently, no such controlled studies have been conducted.
Finally, not only might the telephone be just as eective as face-to-face
counseling, but it may be superior in some regards for certain people. First,
calling for help or information can be a potentially frightening experience as-
sociated with feelings of helplessness. The telephone can enable contact on
non-threatening terms. Second, the telephone oers anonymity which can facil-
itate greater self-revelation and openness. The anonymity may also ease fears
of vulnerability, thereby opening the door to testing. The counselor is anony-
mous as well, allowing the client to make of the counselor what he or she needs.
Third, the telephone can bridge geographic and bureaucratic barriers. The tele-
phone allows an individual to seek help or information without having to run
the gauntlet of bureaucratic procedures (appointments, waiting lists, informa-
tion disclosure) which are necessary for the orderly running of an agency or
clinic.
Thirty-six states have rigorous informed consent laws for AiDS testing.'3
Although a home test would be presumptively voluntary, the decision to take
the test may not be fully informed because pretest counseling would not be
mandatory, even when available (unless the kits were mail order). Thus, the
information booklet would have to be comprehensive and comprehensible.
13 Burns, supra note 1.
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Changing Behavior and Promoting the Public Health: At the heart
of the debate over AIDS home test kits lie ideas and beliefs about how to change
people's behavior and how to best promote the public health, although these are
not always made explicit. Phrased another way, would a home test kit enhance
the public health eorts in the ght against AIDS'?
One argument for requiring that AIDS tests be administered only in profes-
sional health care settings is that for many people, especially racial minorities
and intravenous drug users. the test may be their only avenue into the health
care system. AIDS testing provides a unique opportunity for essential medical
and social services to be introduced to disadvantaged individuals. This argu-
ment rests on an assumption that an AIDS home test would draw clients away
from public clinics. However, it is at least possible that a home test ~vouId
reach people who are already avoiding the clinics. (Many people will undoubt-
edly still prefer a free AIDS test in a medical setting to a home kit that must
be purchased for twenty to thirty dollars.) In this scenario, a person who would
not have otherwise been tested may be notied by a home test that they should
seek tnedical attention, thereby facilitating their entrance into the health care
system.
A related concern is that an AIDS home test kit would become a substitute
for doctors. Medical professionals emphasize that rendering a diagnosis requires
more than a test result~ doctors use clinical impressions, medical history and a
variety of laboratory tests when making a diagnosis. Doctors fear that an AIDS
home test might encourage detrimental self treatment. On the other hand, home
tests may be a viable means of increasing consumer involvement in their own
health|a complement to professional care rather than a substitute.
Although there is no federal reporting requirement for HIV positive results,
several states do have mandatory reporting of HIV infection. Would an AIDS
home test thwart these eorts? While it would be technically possible for the
laboratory to report positive results to state ocials (assuming a blood collection
device), the proposals to date have
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said that they would not market the kits in states with mandatory reporting.
A company would nd it dicult to market a condential home test if the results
had to be reported to state ocials.
And, the ultimate question, will AIDS home tests change people's behavior?
From a public health perspective, until there is a scientic breakthrough, the
only way to control the AIDS epidemic is to slow the transmission of the HIV
virus which in turn requires that people alter their behavior. Will someone who
tests negative with a home kit mistakenly think they are invincible and continue
to engage in unsafe behavior? Will those who test positive take precautions and
notify their sexual partners? Perhaps the question is better asked. is traditional
AIDS testing better at securing behavioral changes?
IV. THE POLITICS OF AIDS AND THE FDA'S ROLE
The FDA is the agency responsible for protecting the public's health.
The above proposition may initially appear sucient to resolve the debate
generated by AIDS home test kits. If medical devices such as AIDS home test
kits are detrimental to the public health, the FDA should keep them o the
market. But once you begin unpacking the term public health. the dicult
questions proliferate. What is the public health? Who is the public? How is
the FDA supposed to assess the public health?
Under x 513(a)(2)(C) of the Medical Device Amendment, the FDA must
nd a medical device safe and eective using a risk/benet analysis. Safety and
eectiveness are determined by weighing the probable benet to health against
the probable risk of injury or illness|a standard purposely less stringent than
that applied to drugs. The statute does not tell us, however, whose benet|
individual or societal. The debate over AIDS home tests has appropriately
considered whether an individual can safely and eectively use the kits. Thus,
the FDA has asked whether the public can collect blood samples and whether
the test yields accurate results.
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But opponents of an AIDS home test suggest other criterion for the safety
and eectiveness of the kits. At the subcommittee hearings, one witness deemed
AIDS home test kits ineective because he believed they would not bring about a
change in risky behaviors. The same witness also found home diagnosis unsafe,
arguing that it would encourage risky behavior in people testing negative.t4
The problem with his reasoning is that it is speculative. When assessing the
impact of a new technology on public health at a macro level, the imagination
reigns. I can conceive a scenario whereby the mass use of AIDS home test kits
wottld result in millions of Americans nding out that they are negative which
in turn might lead to a decrease in public support for AIDS funding which
would adversely aect public health. But intuitions about human nature and
American culture should not be a basis for a federal agency to limit access to a
product.
Who will buy an AIDS home test'? Will people change their behavior?
This paper is full of question marks. The long range, broad imp act of an AIDS
home test kit cannot be known until the product is disseminated. Although the
FDA should not ignore utility of a medical device when considering a PMA, nor
should it allow speculation to control.
Further, when assessing risk, we frequently dodge the issue by using the very
uncertainty at stake, replacing a probability of harm analysis with the possibility
of harm. A critical value judgment being made by everyone, although usually
unstated, is who should bear the burden of uncertainty. While the FDA is used
to facing scientic uncertainty, the uncertainty here is also of the human sort.
As Randy Shilts exhaustively documents in And the Band Played On, in the
early days of the AIDS epidemic uncertainty became an excuse for inaction with
disastrous consequences. Especially given the history of ocial paralysis over
AIDS, when there are no immediate risks to an individual's health, the FDA
should not intervene to remove choices.
14 Testimony of Jose Szapocznik, Ph.D. on behalf of American Psychological
Association before the House Subcommittee on Regulation, Business Opportuni-
ties, and Energy, Risks and Implications of AIDS-l-IIV Testing in Nontraditional
Laboratories and in the Home, 20-21 (March 23, 1989).
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One reason the FDA is now willing to consider the possibility of AIDS home
test kits is that it nally examined the product from a medical perspective.
Since the debate over AIDS home test kits began, the medical profession has
become increasingly convinced of the value of early diagnosis. Early diagno-
sis is important at a societal level in controlling the transmission of the virus
and it is also critical to providing the best medical care to infected individuals.
There are now drugs such as AZT which may prolong the onset of the disease.
Federal health ocials just released new guidelines covering early preventative
treatments of HIV disease.tS If an AIDS home test kit might encourage early di-
agnosis. then its value should not be obscured by endless debates over telephone
versus face-to-face counseling that too much resemble turf wars.
Even though it is private industry pushing for home diagnosis, with some
creative thinking the government may be able to also eectively use the product.
For example, the government cottld give away free home test kits to people in
high risk communities. The AIDS home test kit is not a universal strategy, but
it may be one part of the solution in the ght against AIDS.
Finally, although I am in favor of permitting an AIDS home test go to mar-
ket, I want to consider a more fundamental question: Why would people even
want to take an AIDS test in their home'? The debate over AIDS home test kits
is a product of what some have termed AIDS exceptionalism. AIDS has been
classied dierently and exempted from more traditional approaches to epi-
demics which have historically emphasized identication of the infected. One
reason may be that this is the rst major epidemic since civil liberties achieved
paramount importance in American jurisprudence. The central feature of AIDS
which makes our society so uncomfortable is its transmission through intimate
activities such as sexual relations and childbirth. During the last several decades
our constitutional law tradition and our social ethos have stressed the impor-
tance of
15 Learv, Warren, U.S. Oers Guide for Doctors On Care of those With
H.I.V~, New York Times. A2 1 (Januar~' 21. 1994).
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privacy, especially with regard to intimate associations. Thus, AIDS gener-
ates a tension, if not a collision, between the ethos of public health and civil
liberties. While public health takes the communal well-being as the fundamen-
tal good, civil liberties places individual freedom at the pinnacle. The challenge
is to translate the tension between these abstract notions into a response to a
particular disease.
AIDS home test kits are a logical extension of the tremendous emphasis
placed on privacy and civil liberties in this epidemic. Regardless of whether you
value public health or civil liberties more, the language of privacy may have ob-
scured the analysis with talk of rights and balancing: a crisis and a 'reasonable'
balance rarely coexist. I wonder if secrecy is a sensible way to confront an epi-
demic. The voluntarist consensus which is premised on the stigma surrounding
AIDS may only serve to reinforce it.
My point is not that policy makers should banish value decisions in favor
of a sctentic approach to AIDS; there cannot be an apolitical public health
policy. Rather, decisions about HIV policy will always reect the balance of
moral and political commitments to privacy, reason, and public health and thus
will have a fundamental impact on the social context in which HIV disease will
be transmitted and confronted. Yet it may be time to reverse the question and
ask what are the scientic limits on our political ideology.
15